GlaxoSmithKline PLC Director/PDMR Shareholding (5246D)
February 19 2020 - 12:25PM
UK Regulatory
TIDMGSK
RNS Number : 5246D
GlaxoSmithKline PLC
19 February 2020
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA')
==== ===========================================================================================
a) Name Ms D Waterhouse
==== ====================================== ===================================================
b) Position/status CEO of ViiV Healthcare
==== ====================================== ===================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ===================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ===================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ===================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ===================================================
b) Nature of the Following the vesting on 16 February 2020
transaction of 25% of an award made on 16 February
2015 under the GlaxoSmithKline Deferred
Investment Award programme, Ms Waterhouse
will receive a cash payment of GBP240,634.43
less applicable tax withholding in respect
of 14,421.337 notional Ordinary Shares.
==== ====================================== ===================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ====================== ========================
GBP16.686 14,421.337
================================================================== ========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
=============================================================== ===============================
e) Date of the transaction 2020-02-16
==== ====================================== ===================================================
f) Place of the N/A
transaction
==== ====================================== ===================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHDKLFFBLLLBBL
(END) Dow Jones Newswires
February 19, 2020 12:25 ET (17:25 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Sep 2023 to Sep 2024